The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 19:441-448, November 2007
doi: 10.1176/appi.neuropsych.19.4.441
© 2007 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by van Duijn, E.
* Articles by van der Mast, R.C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by van Duijn, E.
* Articles by van der Mast, R.C.
Related Collections
* Huntington's Disease

Psychopathology in Verified Huntington’s Disease Gene Carriers

E. van Duijn, M.D., E.M. Kingma, M.Sc., M.phil. and R.C. van der Mast, M.D., Ph.D.

Received July 15, 2006; revised November 27, 2006; accepted January 18, 2007. The authors are affiliated with Leiden University Medical Center, Department of Psychiatry, Leiden, the Netherlands. Dr. van Duijn is also affiliated with the Center for Mental Health Care Duin-en Bollenstreek, Rivierduinen, Voorhout, the Netherlands. Address correspondence to Dr. van Duijn, Leiden University Medical Center, Department of Psychiatry, B1-P, PO Box 9600, 2300 RC Leiden, the Netherlands; e.van_duijn{at}lumc.nl (e-mail).

Huntington’s disease is characterized by motor, cognitive, and neuropsychiatric symptoms. This study reviews original research on psychopathology in Huntington’s disease that uses standardized instruments in verified gene carriers. Frequently reported neuropsychiatric symptoms are depressed mood, anxiety, irritability, and apathy, with prevalences of 33% to 76%. Obsessive-compulsive symptoms and psychosis occur less often with prevalences of 10% to 52% and 3% to 11%, respectively. Available research provides little insight into the true prevalences of psychopathology in Huntington’s disease due to small sample sizes, use of different methodologies, and lack of comparison groups. Future research requires larger cohorts stratified to disease stage, consistent methodologies, and adequate comparison groups.







Get information about faster international access.

Privacy Policy

Copyright © 2007 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org